AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+33.49%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.83B
AUM Growth
+$3.83B
(-44%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-110.43%
Top 10 Holdings %
Top 10 Hldgs %
84.96%
Holding
115
New
10
Increased
27
Reduced
10
Closed
11
Top Buys
| 1 |
Scholar Rock
SRRK
|
$37.4M |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$23.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$15.9M |
| 4 |
AUTL
Autolus Therapeutics
AUTL
|
$14.1M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$13.3M |
Top Sells
| 1 |
BUFF
Blue Buffalo Pet Products, Inc
BUFF
|
$3.48B |
| 2 |
WW
WW International
WW
|
$872M |
| 3 |
Incyte
INCY
|
$25M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$19.8M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$12.6M |
Sector Composition
| 1 | Consumer Discretionary | 54.99% |
| 2 | Healthcare | 44.37% |
| 3 | Energy | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $2.1B | 44.73% | 20,818,300 -8,625,000 | -29% | -$872M |
|
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $723M | 15.36% | 60,240,864 +1,966,214 | +3% | +$23.6M |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $104M | 2.21% | 675,000 +75,000 | +13% | +$11.5M |
|
4
Alnylam Pharmaceuticals
ALNY
$58.5B
| $64M | 1.36% | 650,000 +50,000 | +8% | +$4.92M |
|
|
XLRN
5
DELISTED
Acceleron Pharma Inc.
XLRN
| $48.5M | 1.03% | 1,000,000 +150,000 | +18% | +$7.28M |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $45.3M | 0.96% | 2,900,000 +400,000 | +16% | +$6.25M |
|
|
BPMC
7
DELISTED
Blueprint Medicines
BPMC
| $44.4M | 0.94% | 700,000 +250,000 | +56% | +$15.9M |
|
8
Nektar Therapeutics
NKTR
$568M
| $43.9M | 0.93% | 900,000 +200,000 | +29% | +$9.77M |
|
|
9
Scholar Rock
SRRK
$3.14B
| $37.4M | 0.79% | +2,396,040 | New | +$37.4M |
|
10
Atara Biotherapeutics
ATRA
$84.6M
| $36.8M | 0.78% | 1,000,000 -250,000 | -20% | -$9.19M |
|
|
TSRO
11
DELISTED
TESARO, Inc.
TSRO
| $35.6M | 0.76% | 800,000 +200,000 | +33% | +$8.89M |
|
|
ARRY
12
DELISTED
Array Biopharma Inc
ARRY
| $33.6M | 0.71% | 2,000,000 | – | – |
|
|
13
Agios Pharmaceuticals
AGIO
$2.19B
| $29.5M | 0.63% | 350,000 -150,000 | -30% | -$12.6M |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $26.7M | 0.57% | 170,000 +20,000 | +13% | +$3.14M |
|
|
ZGNX
15
DELISTED
Zogenix, Inc.
ZGNX
| $22.1M | 0.47% | 500,000 +300,000 | +150% | +$13.3M |
|
16
Fate Therapeutics
FATE
$120M
| $19.3M | 0.41% | 1,700,000 +850,000 | +100% | +$9.64M |
|
|
ALBO
17
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $17.8M | 0.38% | 500,000 -47,841 | -9% | -$1.7M |
|
18
InflaRx
IFRX
$108M
| $16.1M | 0.34% | 500,000 +375,000 | +300% | +$12.1M |
|
|
SAGE
19
DELISTED
Sage Therapeutics
SAGE
| $15.7M | 0.33% | 100,000 | – | – |
|
20
FibroGen
FGEN
$47.8M
| $15.7M | 0.33% | 250,000 | – | – |
|
21
Xencor
XNCR
$580M
| $14.8M | 0.31% | 400,000 +100,000 | +33% | +$3.7M |
|
|
MDCO
22
DELISTED
Medicines Co
MDCO
| $14.7M | 0.31% | 400,000 +200,000 | +100% | +$7.34M |
|
23
AnaptysBio
ANAB
$569M
| $14.2M | 0.3% | 200,000 +10,000 | +5% | +$710K |
|
|
AUTL
24
Autolus Therapeutics
AUTL
$399M
| $14.1M | 0.3% | +525,000 | New | +$14.1M |
|
25
Madrigal Pharmaceuticals
MDGL
$9.76B
| $14M | 0.3% | 50,000 +5,000 | +11% | +$1.4M |
|